There’s currently no cure for dementia. Although some recently developed drugs show promise in slowing the progress of the ...

Medically reviewed by Femi Aremu, PharmD Dementia is a loss of brain function that affects memory, thinking, judgment, ...

For some people with a high risk of Alzheimer's who received a drug called gantenerumab for eight years, their risk of ...

Eli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the ...

British drugs giant GSK is launching a ground-breaking investigation that could save millions of Britons from developing dementia, The Mail on Sunday can reveal. The trailblazing study will use ...

An early Alzheimer's treatment that removes amyloid plaques from the brain many years before symptoms arise may help delay ...

A new "highly accurate" blood test for Alzheimer's disease also measures how far it has progressed. It could help enable ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

Obesity and diabetes, more common in recent decades, could lead to more dementia, but much touted new drugs that reduce them ...

A long-term human trial has found that a discontinued drug halved the presentation of early-onset Alzheimer's disease in ...

A newly developed blood test for Alzheimer's disease not only aids in the diagnosis of the neurodegenerative condition but also indicates how far it has progressed, according to a new study.